General MedicationsORALStandard
L-GLUTAMINE
L-GLUTAMINE
Standard Dose
5GM/PACKET
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview L-GLUTAMINE is listed in Drugs@FDA under application 215647 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient L-GLUTAMINE Form and strength FOR SOLUTION;ORAL - 5GM/PACKET Sponsor NOVITIUM PHARMA Submission history Latest submission status date: 2024-07-08 00:00:00.
Structured Monograph
Clinical summary
Approval overview L-GLUTAMINE is listed in Drugs@FDA under application 215647 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient L-GLUTAMINE Form and strength FOR SOLUTION;ORAL - 5GM/PACKET Sponsor NOVITIUM PHARMA Submission history Latest submission status date: 2024-07-08 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.